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It is a pleasure for me tn open this Workshop 
on Cell Controls in Psoriasis and to wekome the 
9:1 profes,;ional participants and the d1stmguished 
guests. 
There seems to be throughout the country an 
increasing awareness of psoriasis and the feeling 
that there 1s a need to do more about it. This 
workshop is a 8igmficant and \·aluahle part of an 
intensifying effort to learn more and to do more 
about this serious and important disease. 
Many of you, 1 am sure, attended the lnterna ~ 
twnal SympO!'IUrn on r~oria~:ois held at Stanford 
Unh·ersity in California in early .Jul\' of this year. 
organized by Dr. Eugene Farber who i::. with us 
today. That International Symposium was an 
excellent mix of clinical and basil- infurmatiun 
about psoriasis and was extremely ~uccessful in 
bringing about an exchange of data and ideas 
about this disease. 
The workshop beginning today has a quite dif~ 
ferent purpose. lt will concentrate more clo~el) 
on the fund a mental aspects of cell biology and 
metabolism. hopefull) eliciting information which 
will be the groundwork for future research leading 
to the control of thls serious dbease. 
Precise data un the current pre\'alence, disa 
bility and economic impact of psoriasis a re not 
a\·ailable. It does appear. however, that there are 
perhaps between 5 and 6 million Americans at -
flicted with the disorder. 
A 1963 report by the l\ational Center lor 
Health Statistics based on a sampling of' 294,000 
cases of psoriasis showed i here were annually O\ er 
1 million days ol restrictt>d physical acti\'ity and 
:J6.'5,000 days lost to bed disability. 
The number of dist·harges from the Veterans 
Administration hospitals alone in 1968 provided 
some indication of the morbidity associated with 
psoriasis. In that year, there were 1.09:3 patients 
discharged with a princ1pnl diagnosis of psoriasi~. 
Hospital treaLment of this disea::.e consumed 
.J0,:300 days of nursing carE'. There were 2.149 
other dischar!!'eS from \ 'A ho~pitals that year m 
which psoriash; was recorded as a diagnosis other 
than the prindpal diagnCk.is 
It is important to emphasize that psorial-is b a 
disease requiring main!~ outpatient care. The 
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1970 72 1.\atinnal Health ln ternew Sur\·ey is cur-
rently in progress. Fur the first time since these 
sur\'C.\'s beJ{an. dermatologists in \'8rious parts of 
the country a re serving in an oflic1al capadty as 
members of the mobile health sur\'ey teams. :-Jext 
yea r we shall ha,·e the more precise statistical 
data needed on p~onasis and nn other cutaneou!> 
d1seases. 
A survey on med•ral t>xpenditures ror psonasi" 
made recent!\' bv the National P~;oriasis Founda-
tion suggests· th~ annual cost of treaung this dis-
ease approaches £I billion. 
In 1969. there \\ere 6.100 \eterans on the com-
pensation rolls of the \ 'A in whom the princ1pal 
disability was psoriasis. A \'alue for compensation 
in these ca~es was approximately $1 million. An 
additional 1.000 other veterans on the compensa-
tion rolls had p,;oriasis as a cond1llun other than 
the pnnc1pal disability. 
Federal support of' basic research in p1>oriasis 
has reflected a Jess than opumal effort up to the 
present time. NIH grants coded specifically fm 
psoriasis are \'ery few indeed. although larger 
grams for the numerous clinical research center:. 
study1ng arthritis include funds for dinical in,es-
ligation of psoriasis and psoriatic arthritis. \\bile 
the total outlay for all l\IH research and training 
grants ~upport related to studie!-. involvmg the 
skin is ":lfl million. the amount allocated specifi-
cally for psuriasis hal:> been somewhat less than 
S0.5 million. 
Now, as an important partner in this endea\'Or, 
this Institute welcome); the cooperation and col-
laboration of the :'\ational Psoriaslt-. Foundation. 
\\'e are pleased that Mrs. Beverly Foster. Director 
of the Foundation, will be w1th us during this 
workshop. In instances of other disease categories 
within the responsibilit)- of the National Tnsutute 
of Arthritis and M etabolic Diseases we have 
found various \'oluntary health agencies to be ex -
traordinarily helpful to us m achie\'lng important 
objectives m research and in public education l 
am hopeful the :'\auonal Psoriasis FoundatiOn 
will be an effective partner tn this important 
work. 
We are pleased to have with us a distinguished 
member of the Congress of the lJn1ted States who 
has expre~sed a concern for the psona.:.is problem. 
The Honorable Wendell Wyatt, Representative 
from the First Congressional Distnct of Oregon. 
Despite Mr. Wyatt's busy legislauve schedule he 
has taken the time to provide u~> wllh some intro-
ductory remarks for th1s workshop. 
